Therapeutic Options for Lymphangioleiomyomatosis (LAM): Where We Are and Where We Are Going

F1000 Medicine Reports
doi 10.3410/m1-93
Full Text
Abstract

Available in full text

Date
Authors
Publisher

F1000 Research Ltd